Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60) View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-11

AUTHORS

V. Tormo Ferrero, R. Duque Ugarte, M. Á. Berenguer Francés, R. Cardenal Maciá

ABSTRACT

INTRODUCTION: Endovaginal brachytherapy treatment dosimetry differences were studied using Ir-192 or Co-60 sources for postoperative endometrial cancer. MATERIALS AND METHODS: A prospective descriptive study was conducted. Thirty-six dosimetry plans of different patients were studied (15 by Ir-192 and 21 by Co-60). Variables studied included D2cc Rectum, D2cc Bladder, D2cc Sigmoid, dose percentage at point 0 (applicator surface on the top of the cylinder) and dose percentage at point 1 (5 mm deep on the top of the cylinder). A comparative analysis was performed of the values obtained from each variable between Ir-192 and Co-60 treatments. We compared average of each variables between Iridium and Cobalt by T Student for independent samples (SPSS 22). RESULTS: There were no significant differences on using Ir-192 or Co-60 by variables, except for dose percentage at point 1 in which we detected significant differences (Table 1). Table 1 The results Variables Sources Iridium 192 Cobalt 60 D2cc Rectum (mean dose) [rank] 6.01 Gy [3.99-7.90] 5.28 Gy [3.87-6,34] D2cc Bladder (mean dose) [rank] 5.82 Gy [4.20-8.38] 5.05 Gy [2.23-6.95] D2cc Sigmoid (mean dose) [rank] 4.43 Gy [1.66-6.67] 2.33 Gy [0.60-4.28] Dose percentage at point 0a (mean) [rank] 210.74% [120.90-234.90] 204.75% [177.10-223] Dose percentage at point 1b (mean) [rank] 93.49% [87.30-100.60] 100.11% [96.70-102] aPoint 0: point to the applicator surface bPoint 1: point to 5 mm applicator surface DISCUSSION: Brachytherapy treatment dosimetry plans are similar using Ir-192 or Co-60, except dose percentage at point 1. In the scientific literature, some differences exist and there are some advantages in using cobalt. More... »

PAGES

1409-1413

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x

DOI

http://dx.doi.org/10.1007/s12094-017-1670-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085422610

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28516398


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brachytherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cobalt Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endometrial Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iridium Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organs at Risk", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Planning, Computer-Assisted", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tormo Ferrero", 
        "givenName": "V.", 
        "id": "sg:person.012720576216.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012720576216.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Duque Ugarte", 
        "givenName": "R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berenguer Franc\u00e9s", 
        "givenName": "M. \u00c1.", 
        "id": "sg:person.07654670123.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07654670123.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitari Sant Joan D'Alacant", 
          "id": "https://www.grid.ac/institutes/grid.411263.3", 
          "name": [
            "Radiotherapy Oncology Department, Hospital Universitari Sant Joan d\u00b4Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d\u00b4Alacant, 03550, Alicante, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cardenal Maci\u00e1", 
        "givenName": "R.", 
        "id": "sg:person.011566424025.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011566424025.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00066-008-1684-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012560788", 
          "https://doi.org/10.1007/s00066-008-1684-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5114/jcb.2011.26471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014593945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5114/jcb.2012.27952", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019091925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/bjr.20150010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064565562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/bjr.20150449", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064565726"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-11", 
    "datePublishedReg": "2017-11-01", 
    "description": "INTRODUCTION: Endovaginal brachytherapy treatment dosimetry differences were studied using Ir-192 or Co-60 sources for postoperative endometrial cancer.\nMATERIALS AND METHODS: A prospective descriptive study was conducted. Thirty-six dosimetry plans of different patients were studied (15 by Ir-192 and 21 by Co-60). Variables studied included D2cc Rectum, D2cc Bladder, D2cc Sigmoid, dose percentage at point 0 (applicator surface on the top of the cylinder) and dose percentage at point 1 (5\u00a0mm deep on the top of the cylinder). A comparative analysis was performed of the values obtained from each variable between Ir-192 and Co-60 treatments. We compared average of each variables between Iridium and Cobalt by T Student for independent samples (SPSS 22).\nRESULTS: There were no significant differences on using Ir-192 or Co-60 by variables, except for dose percentage at point 1 in which we detected significant differences (Table\u00a01). Table\u00a01 The results Variables Sources Iridium 192 Cobalt 60 D2cc Rectum (mean dose) [rank] 6.01\u00a0Gy [3.99-7.90] 5.28\u00a0Gy [3.87-6,34] D2cc Bladder (mean dose) [rank] 5.82\u00a0Gy [4.20-8.38] 5.05\u00a0Gy [2.23-6.95] D2cc Sigmoid (mean dose) [rank] 4.43\u00a0Gy [1.66-6.67] 2.33\u00a0Gy [0.60-4.28] Dose percentage at point 0a (mean) [rank] 210.74% [120.90-234.90] 204.75% [177.10-223] Dose percentage at point 1b (mean) [rank] 93.49% [87.30-100.60] 100.11% [96.70-102] aPoint 0: point to the applicator surface bPoint 1: point to 5\u00a0mm applicator surface DISCUSSION: Brachytherapy treatment dosimetry plans are similar using Ir-192 or Co-60, except dose percentage at point 1. In the scientific literature, some differences exist and there are some advantages in using cobalt.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12094-017-1670-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1035367", 
        "issn": [
          "1699-048X", 
          "1699-3055"
        ], 
        "name": "Clinical and Translational Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60)", 
    "pagination": "1409-1413", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4904f4e26f1f694871febf9b02cae1982dbb5f64c105d900eabf65fd817f0c53"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28516398"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101247119"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12094-017-1670-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085422610"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12094-017-1670-x", 
      "https://app.dimensions.ai/details/publication/pub.1085422610"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89785_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12094-017-1670-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12094-017-1670-x'


 

This table displays all metadata directly associated to this object as RDF triples.

161 TRIPLES      21 PREDICATES      48 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12094-017-1670-x schema:about N1e5ed7255e1440f485630d12715a576d
2 N35c00bc898554ad3afdb7c47118dc7b2
3 N6110f10b469747beadb2fe3567025c7f
4 N6aac704ece5b4e5cb027188338b28404
5 N7024c2406855488aa518324c3a43b534
6 N84480d5bed8342baa3b0edb7c37a79bf
7 N84740058c48344b9a2d5d552a613d5f6
8 N8527152c255c4c869f5ffb5ccc44dd5e
9 N9debd7d7c01a4306a0acde86df8f203a
10 N9f2e7f1843604d36993420762522b62a
11 Nb2d0b8fb7f204234864996ccb564bd5d
12 Nb58b2c2879f74170b842d7476f0293eb
13 Nb61af4ac68bf4bf2beb11f6966e860a9
14 Neef8a7bb3ed34d83859a7fe4affc7990
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N63824086732b4e9b89225cffc038431b
18 schema:citation sg:pub.10.1007/s00066-008-1684-y
19 https://doi.org/10.1259/bjr.20150010
20 https://doi.org/10.1259/bjr.20150449
21 https://doi.org/10.5114/jcb.2011.26471
22 https://doi.org/10.5114/jcb.2012.27952
23 schema:datePublished 2017-11
24 schema:datePublishedReg 2017-11-01
25 schema:description INTRODUCTION: Endovaginal brachytherapy treatment dosimetry differences were studied using Ir-192 or Co-60 sources for postoperative endometrial cancer. MATERIALS AND METHODS: A prospective descriptive study was conducted. Thirty-six dosimetry plans of different patients were studied (15 by Ir-192 and 21 by Co-60). Variables studied included D2cc Rectum, D2cc Bladder, D2cc Sigmoid, dose percentage at point 0 (applicator surface on the top of the cylinder) and dose percentage at point 1 (5 mm deep on the top of the cylinder). A comparative analysis was performed of the values obtained from each variable between Ir-192 and Co-60 treatments. We compared average of each variables between Iridium and Cobalt by T Student for independent samples (SPSS 22). RESULTS: There were no significant differences on using Ir-192 or Co-60 by variables, except for dose percentage at point 1 in which we detected significant differences (Table 1). Table 1 The results Variables Sources Iridium 192 Cobalt 60 D2cc Rectum (mean dose) [rank] 6.01 Gy [3.99-7.90] 5.28 Gy [3.87-6,34] D2cc Bladder (mean dose) [rank] 5.82 Gy [4.20-8.38] 5.05 Gy [2.23-6.95] D2cc Sigmoid (mean dose) [rank] 4.43 Gy [1.66-6.67] 2.33 Gy [0.60-4.28] Dose percentage at point 0a (mean) [rank] 210.74% [120.90-234.90] 204.75% [177.10-223] Dose percentage at point 1b (mean) [rank] 93.49% [87.30-100.60] 100.11% [96.70-102] aPoint 0: point to the applicator surface bPoint 1: point to 5 mm applicator surface DISCUSSION: Brachytherapy treatment dosimetry plans are similar using Ir-192 or Co-60, except dose percentage at point 1. In the scientific literature, some differences exist and there are some advantages in using cobalt.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N9e0253cd5f044002877ef77bfe7d4bc8
30 Nb89b261904614dd99d656393bb85b13c
31 sg:journal.1035367
32 schema:name Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60)
33 schema:pagination 1409-1413
34 schema:productId N36c42727e8984cbbb4e8a29da700deda
35 N6c43d91d1ce74901834b7aa1deb9a250
36 N77eb3ecd41ed47178f14844178142b5a
37 N865e4f22e03f4e36966953c46d658add
38 Nc1912b1cbcfc4579af3f9c5b7f723f43
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085422610
40 https://doi.org/10.1007/s12094-017-1670-x
41 schema:sdDatePublished 2019-04-11T09:49
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher Nb6d9d2922b73452596a584f7dd306630
44 schema:url https://link.springer.com/10.1007%2Fs12094-017-1670-x
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N1e5ed7255e1440f485630d12715a576d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Radiotherapy Planning, Computer-Assisted
50 rdf:type schema:DefinedTerm
51 N257c2a68c46941f58059966850a6989c rdf:first Ne8630dcb36b84d2b9c2a8f3eb56b414b
52 rdf:rest Ne97014e2bf084b4fbbae94d0d7c7c08c
53 N35c00bc898554ad3afdb7c47118dc7b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Radiotherapy Dosage
55 rdf:type schema:DefinedTerm
56 N36c42727e8984cbbb4e8a29da700deda schema:name pubmed_id
57 schema:value 28516398
58 rdf:type schema:PropertyValue
59 N5afcd6bd3e0b402aae2e550af37fecb6 rdf:first sg:person.011566424025.18
60 rdf:rest rdf:nil
61 N6110f10b469747beadb2fe3567025c7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Follow-Up Studies
63 rdf:type schema:DefinedTerm
64 N63824086732b4e9b89225cffc038431b rdf:first sg:person.012720576216.16
65 rdf:rest N257c2a68c46941f58059966850a6989c
66 N6aac704ece5b4e5cb027188338b28404 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Cobalt Radioisotopes
68 rdf:type schema:DefinedTerm
69 N6c43d91d1ce74901834b7aa1deb9a250 schema:name doi
70 schema:value 10.1007/s12094-017-1670-x
71 rdf:type schema:PropertyValue
72 N7024c2406855488aa518324c3a43b534 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Humans
74 rdf:type schema:DefinedTerm
75 N77eb3ecd41ed47178f14844178142b5a schema:name nlm_unique_id
76 schema:value 101247119
77 rdf:type schema:PropertyValue
78 N84480d5bed8342baa3b0edb7c37a79bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Prognosis
80 rdf:type schema:DefinedTerm
81 N84740058c48344b9a2d5d552a613d5f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Prospective Studies
83 rdf:type schema:DefinedTerm
84 N8527152c255c4c869f5ffb5ccc44dd5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Female
86 rdf:type schema:DefinedTerm
87 N865e4f22e03f4e36966953c46d658add schema:name readcube_id
88 schema:value 4904f4e26f1f694871febf9b02cae1982dbb5f64c105d900eabf65fd817f0c53
89 rdf:type schema:PropertyValue
90 N9debd7d7c01a4306a0acde86df8f203a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Postoperative Care
92 rdf:type schema:DefinedTerm
93 N9e0253cd5f044002877ef77bfe7d4bc8 schema:issueNumber 11
94 rdf:type schema:PublicationIssue
95 N9f2e7f1843604d36993420762522b62a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Radiometry
97 rdf:type schema:DefinedTerm
98 Nb2d0b8fb7f204234864996ccb564bd5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Organs at Risk
100 rdf:type schema:DefinedTerm
101 Nb58b2c2879f74170b842d7476f0293eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Brachytherapy
103 rdf:type schema:DefinedTerm
104 Nb61af4ac68bf4bf2beb11f6966e860a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Iridium Radioisotopes
106 rdf:type schema:DefinedTerm
107 Nb6d9d2922b73452596a584f7dd306630 schema:name Springer Nature - SN SciGraph project
108 rdf:type schema:Organization
109 Nb89b261904614dd99d656393bb85b13c schema:volumeNumber 19
110 rdf:type schema:PublicationVolume
111 Nc1912b1cbcfc4579af3f9c5b7f723f43 schema:name dimensions_id
112 schema:value pub.1085422610
113 rdf:type schema:PropertyValue
114 Ne8630dcb36b84d2b9c2a8f3eb56b414b schema:affiliation https://www.grid.ac/institutes/grid.411263.3
115 schema:familyName Duque Ugarte
116 schema:givenName R.
117 rdf:type schema:Person
118 Ne97014e2bf084b4fbbae94d0d7c7c08c rdf:first sg:person.07654670123.73
119 rdf:rest N5afcd6bd3e0b402aae2e550af37fecb6
120 Neef8a7bb3ed34d83859a7fe4affc7990 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Endometrial Neoplasms
122 rdf:type schema:DefinedTerm
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
127 schema:name Clinical Sciences
128 rdf:type schema:DefinedTerm
129 sg:journal.1035367 schema:issn 1699-048X
130 1699-3055
131 schema:name Clinical and Translational Oncology
132 rdf:type schema:Periodical
133 sg:person.011566424025.18 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
134 schema:familyName Cardenal Maciá
135 schema:givenName R.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011566424025.18
137 rdf:type schema:Person
138 sg:person.012720576216.16 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
139 schema:familyName Tormo Ferrero
140 schema:givenName V.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012720576216.16
142 rdf:type schema:Person
143 sg:person.07654670123.73 schema:affiliation https://www.grid.ac/institutes/grid.411263.3
144 schema:familyName Berenguer Francés
145 schema:givenName M. Á.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07654670123.73
147 rdf:type schema:Person
148 sg:pub.10.1007/s00066-008-1684-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1012560788
149 https://doi.org/10.1007/s00066-008-1684-y
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1259/bjr.20150010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064565562
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1259/bjr.20150449 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064565726
154 rdf:type schema:CreativeWork
155 https://doi.org/10.5114/jcb.2011.26471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014593945
156 rdf:type schema:CreativeWork
157 https://doi.org/10.5114/jcb.2012.27952 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019091925
158 rdf:type schema:CreativeWork
159 https://www.grid.ac/institutes/grid.411263.3 schema:alternateName Hospital Universitari Sant Joan D'Alacant
160 schema:name Radiotherapy Oncology Department, Hospital Universitari Sant Joan d´Alacant, Ctra. Nnal. 332 Alicante-Valencia, s/n, Sant Joan d´Alacant, 03550, Alicante, Spain
161 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...